Veludacigib

N/A

Report date: 2025/05/23 12:02:23
NMEFirst In Class

Base Information

Drug NameVeludacigib
Drug Alias NameBAY2965501BAY-2965501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiacylglycerol kinase zeta inhibitors
TargetsDiacylglycerol kinase zeta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesUnited Kingdom +[7
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A